$370K+ in pipeline routed across 4 sectors · last quarter
Shareef and Saad ↗ route pre-vetted active buyers, capital, and dealflow to supply partners and operators, qualifying both sides before any introduction is made.
Selective mandates across capital, growth, and strategic introductions.
Commercial cleaning & facilities · Wealth management · Pharmacy supply · AI automations
Read memorandum →Case studies →Book private consultation →
- →U.S. janitorial services revenue is on track to reach $112.4B in 2026, with the commercial subset growing faster at 6–7% — new contract volume outpacing the market average.
- →Roark Capital's ServiceMaster Brands platform has scaled past $5.5B+ enterprise value through an aggressive franchise and acquisition rollup, with ABM Industries and Aramark consolidating in parallel at the strategic level.
- →SoftBank Robotics America acquired Green Clean Commercial in March 2026, a signal of technology-driven consolidation reshaping who wins the next round of contracts.
- →The market stays highly fragmented — a surge of new entrants is fighting over the same contracts, with clean diversified books trading at 6–7x EBITDA versus 3–4x for concentrated ones.
Sources: IBISWorld, CT Acquisitions, industry M&A reporting (2026).
Wealth management- →RIA Mergers & Acquisitions hit its most active second quarter on record in Q2 2026: 120 transactions, $378B in AUM transacted.
- →First-half 2026 RIA deal count is up nearly 40% year-over-year: 262 deals through H1, versus 220 in H1 2025.
- →Wealth Enhancement closed its third $1B+ breakaway deal of 2026, lifting a six-advisor team managing $1.2B off TFB Advisors.
- →Family office formation keeps accelerating: 119 new family office profiles identified in Q1 2026 alone, driven by tech and entrepreneurial wealth.
Sources: ECHELON Partners, InvestmentNews, WealthManagement.com, FINTRX (2026).
Pharmacy supply- →Active U.S. drug shortages rose for a third straight quarter in 2026, with ASHP counting 227 active national shortages — independents scrambling for a second source.
- →Sterile injectables now make up 71% of all shortages, the largest of any dosage form, as reliance on single suppliers keeps breaking the chain.
- →Three wholesalers — McKesson, AmerisourceBergen and Cardinal Health — control over 90% of drug distribution, leaving independents bottlenecked even when supply exists upstream.
- →Average shortage duration now exceeds 5 years — what used to be a transient gap has become a standing opportunity for a second wholesaler relationship.
Sources: ASHP, AJMC, Pharmacy Times, Bloodworth Wholesale Drugs (2026).
- $100K in revenuein 1 quarter · Account onboarded
- $85K+ in new revenuein under 60 days · Pharmacy supply
- 6 qualified introsin 46 days · Wealth management
- 2 strategic partnersin 60 days · Healthcare
- 17 job placement ordersin 49 days · Recruitment
- 5 new clientsin 48 days · Education SaaS
A sample of recent matches closed across account onboarding, pharmacy supply, wealth management, healthcare, recruitment, and education SaaS. In partnership with myoProcess.
Forthcoming: The Advisor Lift-Out Window · What a Distributor Actually Diligences · How Roasters Choose a Green Coffee Broker.